Karuna Therapeutics Readies Plan For $70 Million IPO

6/23/19

By Donovan Jones, SeekingAlpha

Karuna Therapeutics has filed to raise $70 million in a U.S. IPO.

The firm is advancing a pipeline of treatment candidates for schizophrenia and other central nervous system disorders.

Management expects a late 2019 time frame for publishing topline results from its lead Phase 2 trial program.

For patient life science investors with at least a one-year hold period, the IPO may be worth considering.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.